Verve Therapeutics, Inc.
| File:Verve Therapeutics logo.png | |
| Public | |
| Traded as | NASDAQ: VERV |
| ISIN | 🆔 |
| Industry | Biotechnology research and development |
| Founded 📆 | 2018 |
| Founder 👔 | |
| Headquarters 🏙️ | 500 Technology Square Cambridge, Massachusetts, U.S. |
Area served 🗺️ | |
Key people | Sekar Kathiresan (CEO)[1] |
| Members | |
Number of employees | |
| 🌐 Website | www.vervetx.com |
| 📇 Address | |
| 📞 telephone | |
Verve Therapeutics, Inc. is a Cambridge, Massachusetts-based biotechnology company that is focused on using CRISPR and gene editing techniques to treat coronary artery and cardiovascular disease.[2][3]
History[edit]
Verve Therapeutics was founded in 2018 by Sekar Kathiresan, and other researchers in the area of cardiovascular genetics including Kiran Musunuru and J. Keith Joung.[4] Verve's initial two programs target PCSK9 and ANGPTL3, two genes which have been validated by human genetics and pharmacology to be targets for lowering blood lipids.[5] The company completed its initial public offering on the Nasdaq in June 2021, raising gross proceeds of $266.7 million.[6]
References[edit]
- ↑ "A 'Cure for Heart Disease'? A Single Shot Succeeds in Monkeys". The New York Times. Retrieved 3 July 2021.(Subscription required.)
- ↑ "Verve Therapeutics Explodes out of Stealth Mode to Focus on Gene Therapies for Cardiovascular Disease". BioSpace. Retrieved 3 July 2021.
- ↑ "Crispr's Next Frontier: Treating Common Conditions". The Wall Street Journal. Retrieved 3 July 2021.
- ↑ "CRISPR Startups Give Genome Editing Several New Twists". Genetic Engineering & Biotechnology News. Retrieved 3 July 2021.
- ↑ "CRISPR 2.0: Base Editing in the Groove". Genetic Engineering & Biotechnology News. Retrieved 3 July 2021.
- ↑ "Verve Therapeutics Announces Pricing of Initial Public Offering". Business Wire. Retrieved 3 July 2021.
External links[edit]
This article "Verve Therapeutics" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Verve Therapeutics. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
- Companies based in Cambridge, Massachusetts
- Biotechnology companies of the United States
- Biotechnology companies established in 2018
- Health care companies based in Massachusetts
- American companies established in 2018
- 2018 establishments in Massachusetts
- 2021 initial public offerings
- Companies listed on the Nasdaq
